deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BLACKMORES LIMITED (ASX.BKL)

ASX, Legal & CGT Status
Former (or subsequent) names
CompanyFROMTO
BLACKMORES LIMITED07/12/1989
BLACKMORES LABORATORIES LIMITED07/12/1989
Shareholder links
Our website ranking of BKL: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare Sydney
6 Hope St Ermington NSW 2115
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details
ISIN: AU000000BKL7
Address: 20 Jubilee Avenue, WARRIEWOOD, NSW, AUSTRALIA, 2102
Tel:  61-2- 9910 5000 Fax: 61-2- 9910 5555

Date first listed: 02/05/1985

Sector: Household & Personal Products
Industry Group: XSJ
Activities: Develops and markets natural healthcare products and services

delisted at entity's request under Listing Rule 17.11

11/08/2023

we understand Kirin Health Science Australia Pty Ltd, a wholly owned subsidiary of Kirin Holdings Company Limited, acquired all of the issued shares in Blackmores for $91.71 cash per Blackmores share

11/08/2023

The Scheme of Arrangement under which Kirin Health Science Australia Pty Ltd, a wholly owned subsidiary of Kirin Holdings Company, Limited, will acquire all of the issued shares in Blackmores has been implemented today. Accordingly, Kirin Sub now holds all of the shares on issue in Blackmores. An amount of $91.71 cash per Blackmores Share has been sent to Blackmores Shareholders today in respect of all Blackmores Shares held on the Scheme Record Date, being 7:00pm (Sydney time) on 2 August 2023. The fully franked special dividend of $3.29 per Blackmores Share was paid on 1 August 2023 to those shareholders who held Blackmores Shares on the record date for the Special Dividend, being 7:00pm (Sydney time) on 26 July 2023.

10/08/2023

The company releases a notification of cessation of securities.

08/08/2023

The securities of Blackmores Limited will be suspended from quotation at the close of trading today, Friday, 21 July 2023 under Listing Rule 17.2, following lodgement of the orders of the Federal Court of Australia with ASIC approving the scheme of arrangement by which Kirin Health Science Australia Pty Ltd will acquire all of the issued shares of BKL.

21/07/2023

name changed from Blackmores Laboratories Limited

07/12/1989
View ASX Announcements (courtesy of ASX)

 

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    25/02/2023Erica Mann17$82.453$1,402
    15/09/2022Anne Templeman-Jones650$69.090$44,909
    01/09/2022Anne Templeman-Jones320$67.680$21,658
    30/08/2022Stephen Roche750$68.580$51,435
    22/08/2022Sharon Warburton565$69.980$39,539

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    Wendy StopsChairman28/04/2021
    Alastair SymingtonManaging Director, CEO01/10/2019
    Patrick GibsonCFO28/02/2022
    Sharon WarburtonIndependent Director28/04/2021
    Erica MannIndependent Director20/09/2021
    Stephen RocheIndependent Director20/09/2021
    Helen MediatiCompany Secretary
    Lyn NikolopoulosCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)
    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Anne Templeman-JonesNon Exec Chairman28/10/202025/11/2022
    David AnsellInterim Chairman, Independent Director22/10/201330/06/2022
    Gunther BurghardtCFO06/01/202028/02/2022
    Christine HolmanNon Exec Director18/03/201928/07/2021
    Brent WallaceNon Exec Chairman19/10/200527/10/2020
    Marcus BlackmoreExecutive Director, CEO27/10/197323/10/2020
    John ArmstrongIndependent Director05/05/201508/09/2020
    Aaron CanningCFO26/02/201506/01/2020
    Helen NashNon Exec Director22/10/201306/08/2019
    Jackie McArthurNon Exec Director24/04/201806/08/2019
    David FenlonManaging Director30/09/201316/05/2019
    Richard HenfreyManaging Director, CEO17/08/201729/03/2019
    Stephen ChapmanDirector30/09/199327/11/2018
    Christine HolgateManaging Director24/09/200829/09/2017
    Chris LastCFO01/03/201026/02/2015
    Verilyn FitzgeraldNon Exec Director07/05/199723/10/2014
    Robert StovoldNon Exec Director28/08/199622/10/2013
    Adrian SturrockInvestor Relations01/05/200930/09/2013
    Naseema SparksNon Exec Director19/10/200525/10/2012
    Rananda RichInvestor Relations01/09/200931/07/2011
    Jennifer TaitCOO, General Manager23/10/200328/08/2008
    Anthony PascoeCEO22/12/2006
    Bill CutbushDeputy Chairman09/10/198819/10/2005

    Date of first appointment, title may have changed.